Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
Clinical trial NCT00371553 · COMPLETED
Trial details
- NCT number
- NCT00371553
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.